DUBLIN, Nov. 10, 2017 /PRNewswire/ -- Perrigo
Company plc (NYSE: PRGO; TASE) today announced that John T. Hendrickson, Perrigo Chief Executive
Officer, will present at the 2017 Stifel Healthcare Conference at
8:45 AM EST on Tuesday, November 14, 2017. Interested
parties can access the presentation webcast at
http://perrigo.investorroom.com/events-webcasts.
About Perrigo
Perrigo Company plc, a leading global healthcare company,
delivers value to its customers and consumers by providing
Quality Affordable Healthcare Products®. Founded
in 1887 as a packager of home remedies, Perrigo has built a unique
business model that is best described as the convergence of a
fast-moving consumer goods company, a high-quality pharmaceutical
manufacturing organization and a world-class supply chain network.
Perrigo is one of the world's largest manufacturers of
over-the-counter ("OTC") healthcare products and suppliers of
infant formulas for the store brand market. The Company also is a
leading provider of branded OTC products throughout Europe and the U.S., as well as a leading
producer of "extended topical" prescription drugs. Perrigo,
headquartered in Ireland, sells
its products primarily in North
America and Europe, as well
as in other markets, including Australia, Israel and China. Visit Perrigo online at
(http://www.perrigo.com).
Forward-Looking Statements
Certain statements in this press release are "forward-looking
statements." These statements relate to future events or the
Company's future financial performance and involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those
expressed or implied by any forward-looking statements. In some
cases, forward-looking statements can be identified by terminology
such as "may," "will," "could," "would," "should," "expect,"
"plan," "anticipate," "intend," "believe," "estimate," "predict,"
"potential" or the negative of those terms or other comparable
terminology. The Company has based these forward-looking statements
on its current expectations, assumptions, estimates and
projections. While the Company believes these expectations,
assumptions, estimates and projections are reasonable, such
forward-looking statements are only predictions and involve known
and unknown risks and uncertainties, many of which are beyond the
Company's control, including: the timing, amount and cost of any
share repurchases; future impairment charges; the success of
management transition; customer acceptance of new products;
competition from other industry participants, some of whom have
greater marketing resources or larger market shares in certain
product categories than the Company does; pricing pressures from
customers and consumers; potential third-party claims and
litigation, including litigation relating to the Company's
restatement of previously-filed financial information; potential
impacts of ongoing or future government investigations and
regulatory initiatives; resolution of uncertain tax positions; the
impact of U.S. tax reform legislation; general economic conditions;
fluctuations in currency exchange rates and interest rates; the
consummation of announced acquisitions or dispositions, and the
Company's ability to realize the desired benefits thereof; the
Company's ability to achieve its guidance; and the Company's
ability to execute and achieve the desired benefits of announced
cost-reduction efforts and other initiatives. In addition,
the Company may identify and be unable to remediate one or more
material weaknesses in its internal control over financial
reporting. Furthermore, the Company and/or its subsidiaries may
incur additional tax liabilities in respect of 2016 and prior years
as a result of any restatement or may be found to have breached
certain provisions of Irish company legislation in respect of prior
financial statements and if so may incur additional expenses and
penalties. These and other important factors, including those
discussed under "Risk Factors" in the Company's Form 10-K for the
year ended December 31, 2016, as well as the Company's
subsequent filings with the United States Securities and Exchange
Commission, may cause actual results, performance or achievements
to differ materially from those expressed or implied by these
forward-looking statements. The forward-looking statements in this
press release are made only as of the date hereof, and unless
otherwise required by applicable securities laws, the Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
View original content with
multimedia:http://www.prnewswire.com/news-releases/perrigo-company-to-present-at-the-stifel-2017-healthcare-conference-300553950.html
SOURCE Perrigo Company plc